Skip to content
PICO Portalanswers from OpenAlex

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

PaperCitations, authors & open-access status

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial have?

PICO Portalcitation count

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial has 901 citations in the OpenAlex counts PICO Portal stores.

When was Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial published?

PICO Portalyear

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial has 2015 year in the PICO Portal index.

What is the open-access status of Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial?

PICO Portaloa status

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial has closed oa status in the PICO Portal index.

What is the DOI of Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial?

PICO Portaldoi

The DOI for Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial is on the source record.

What is the PMID of Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial?

PICO Portalpmid

The PMID for Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial is on the source record.

What is the OpenAlex record for Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial?

PICO Portalopenalex

The OpenAlex for Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial